Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ADTX
ADTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ADTX News
Aditxt Shares to Lose Nasdaq Listing After Appeal Rejected
Jun 25 2026
stocktwits
Nasdaq Set for Worst Opening in Weeks Amid Tech Selloff
Jun 23 2026
stocktwits
Takeover Time 2026 LLC Acquires 10.9% Stake in Aditxt
Jun 23 2026
stocktwits
Biotech Stocks Show Significant Pre-Market Activity
Jun 18 2026
NASDAQ.COM
U.S. and Iran Sign Memorandum of Understanding
Jun 18 2026
stocktwits
Traders Eye PPI and Adobe Earnings Amid Geopolitical Tensions
Jun 11 2026
stocktwits
ADTX Shares Plunge 36%, Extending Record 22-Day Losing Streak
Jun 11 2026
stocktwits
Aditxt's Ignite Subsidiary Set for Independent IPO
Jun 09 2026
stocktwits
Aditxt Announces Business Combination with Ignite Proteomics
Jun 09 2026
seekingalpha
Aditxt Appoints Jeffrey M. Busch as Interim CEO
Jun 01 2026
seekingalpha
Aditxt Executes Third Reverse Stock Split in Seven Months
May 14 2026
stocktwits
Aditxt Announces 1-for-27 Reverse Stock Split
May 14 2026
seekingalpha
Ignite's Platform Shows Advantage in HER2 Testing
Apr 20 2026
Newsfilter
Aditxt Appoints Jeff Busch as CEO of Ignite Proteomics to Drive Growth
Mar 19 2026
Newsfilter
Aditxt Acquires Ignite Proteomics for $36M in Preferred Shares
Mar 13 2026
seekingalpha
Aditxt Acquires Ignite to Optimize Cancer Treatment Selection
Mar 13 2026
Newsfilter
Show More News
